Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Doener F, Hong HS, Meyer I, Tadjalli-Mehr K, et al. RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial. Vaccine 2019 Feb 21. pii: S0264-410X(19)30219.
PMID: 30797640


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016